# A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607

> **NCT02737007** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 6 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** [14C]-GSK3191607

## Key facts

- **NCT ID:** NCT02737007
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-18
- **Primary completion:** 2016-05-12
- **Final completion:** 2016-05-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737007, "A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02737007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*